INJECTABLE ADIPOSE MATRIX IMPROVES HEALING RATES

The use of a new tissue allograft, which can be injected into areas of high pressure in the foot, has demonstrated clinical improvement in a number of real-life cases, according to a presentation delivered at the Desert Foot Conference. Described as “an adipose matrix” derived from another part of the human body, speaker Jodi Schoenhaus, DPM told those in attendance that “this technology is going to change the wound care world in the next 10 years”.

 

Dr. Jodi Schoenhaus

 

Introducing the matrix, Schoenhaus said: “This product is the first of its kind in this arena, and we are able to use the graft for diabetic foot ulcer (DFU) prevention, fat pad reconstruction, pressure ulcers, and even deep tunnelling wounds.” It was explained further that Leneva is produced by taking tissue from a donor, before it is processed by MTF Biologics and ultimately injected (or placed around) a patient’s fat pad.

 

Source: iWoundsnews [1/3/20] 

Courtesy of Barry Block, editor of PM News